NanoMuG earned third place at Startup Marathon 2025, one of the most significant Italian competitions dedicated to deep-tech innovation. The event, hosted at UniCredit’s headquarters in Milan on November 20, brought together twelve startups selected from nearly sixty applications submitted by incubators, research centers, and universities across Italy.
Our technology was recognized by the jury as one of the most promising solutions for the future of pharmacological therapies.
A recognition that strengthens our growth trajectory
Reaching the podium at Startup Marathon 2025 confirms the robustness of our scientific approach, our technological roadmap, and the impact our platform can generate within the pharmaceutical and biotech sectors.
Being among the top three startups in such a highly competitive and high-level context highlights the relevance of our contribution to transforming mucosal medicine and advanced drug delivery. Being finalists of Startup Marathon also grants access to valuable networking and growth opportunities, including privileged access to the Executive MBA in Business Innovation at MIB Trieste School of Management and the chance to engage with corporate and technological partners within the Open Innovation programs.